Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Manual Lymphatic Drainage on Swelling After Orthognathic Surgery - a Qualitative and 3D Facial Analysis.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03682159
Recruitment Status : Completed
First Posted : September 24, 2018
Last Update Posted : February 4, 2019
Sponsor:
Information provided by (Responsible Party):
Tandheelkunde, University Hospital, Ghent

Brief Summary:

Introduction / background

Orthognathic surgery is an operation in which one or both jaws are fixed in a more favorable position performed by an osteotomy. In this way, large skeletal differences between the upper and lower jaw can be corrected surgically. The aim is to obtain a good and stable occlusion as well as to improve the facial aesthetics off the patient, where this would not be possible without surgery. These surgical procedures are accompanied by swelling of the face that can last for several days. The swelling is often considered unpleasant by the patients. The post-operative application of ice on the face can reduce the swelling. Also, performing manual lymphatic drainage (MLD) at the head and neck region would have a positive effect on the swelling after the operation. Manual lymphatic drainage is a kind of gentle massage performed by physiotherapists to reduce swelling in a faster way after surgery. This therapy is performed during the first days after the surgery and lasts about 30 minutes per session. There is still insufficient evidence to be whether or not this technique offers added value for patients undergoing jaw surgery.

Goal

The aim of this study is to investigate whether or not manual lymphatic drainage provides added value for patients undergoing jaw surgery. The facial swelling will be studied as the primary outcome variable. Other postoperative discomforts associated with orthognathic surgery are the secondary outcome variables. This study may or may not justify performing MLD and ensure that it is included in a postoperative protocol.

Methodological approach

The investigators would like to measure and compare the swelling in the face in an objective way between patients who received manual lymphatic drainage (intervention group) and patients who did not undergo manual lymphatic drainage (control group) The control group receives the standard postoperative care that is applied at the University Hospital Ghent. The intervention group also receives the same postoperative cares, as well as 5 MLD sessions during the first postoperative week (1st, 2nd, 3rd, 4th, 7th postoperative day).The objective measurement of the swelling can be done on the basis of a laser scan that can create 3D images of the face. For this, the patient should take a natural head position at rest and have a relaxed facial expression. This technique of imaging is non-invasive and there is no x-ray radiation involved! The 3D images are taken at the following times: 3 days, 1 week, 2 weeks, 1 month, 3 months and 6 months after the operation. Together with the scans, the patients were asked to fill in a questionnaire to frame the subjective postoperative discomfort associated with orthognathic surgery.

The change in swelling can be analyzed on the basis of specific measurements on the 3D images as well as by recording surface changes. The last 3D image is used as a reference to superimpose the other 3D images as there is no longer any swelling on this 3D image. After analyzing these data, it can be assessed to what extent manual lymphatic drainage offers an advantage to reduce swelling after orthognathic surgery.


Condition or disease Intervention/treatment Phase
Postoperative Care/Methods Drainage/Methods Edema/Prevention & Control Orthognathic Surgical Procedures/Adverse Effects Other: manual lymphatic drainage Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 26 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Care Provider, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: The Effect of Manual Lymphatic Drainage on Swelling After Orthognathic Surgery - a Qualitative and 3D Facial Analysis.
Study Start Date : September 2016
Actual Primary Completion Date : April 2018
Actual Study Completion Date : September 2018

Arm Intervention/treatment
No Intervention: control
Experimental: intervention Other: manual lymphatic drainage
The intervention group received the same conventional postoperative cares as the control group, but also underwent 5 sessions of manual lymphatic drainage (MLD)




Primary Outcome Measures :
  1. Change of swelling after orthognathic surgery assessed by 3D face scans [ Time Frame: At the 3th, 7th and 14th day after surgery, as well as 1 month, 3 months and 6 months after surgery. ]
    3D face scans were taken with the Planmeca Proface® (Planmeca Oy, Finland) at 6 fixed time points after surgery to measure change in facial swelling. This was done by superimposition of the different scans. Swelling was expressed in millimeters.


Secondary Outcome Measures :
  1. Questionnaire with a 100 millimeter Visual Analogue Scale to measure perceived pain [ Time Frame: At the 3th, 7th and 14th day after surgery, as well as 1 month, 3 months and 6 months after surgery. ]
    Pain scores were assessed at 6 fixed time points after surgery using a visual analogue scale (VAS) of 100 mm, representing all pain sensations from none to maximum. Zero mm indicates no pain, 50 mm moderate pain and 100 mm worst pain possible. Patients were asked to place a mark along the line that corresponded to the amount of pain they were experiencing.

  2. Questionnaire with a five-point Likert-type Scale to measure perceived swelling [ Time Frame: at the 3th, 7th and 14th day after surgery, as well as 1 month, 3 months and 6 months after surgery. ]
    Swelling was assessed at 6 fixed time points after surgery using a five-point Likert-type Scale. Five possible answers could be checked: no swelling, almost no swelling, moderate swelling, pretty much swelling and very much swelling.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   14 Years to 65 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age 14 - 65 years
  • ASA score I
  • BSSO, LeFort I or Bimax

Exclusion Criteria:

  • Transgender patients
  • Other facial surgery's
  • Deviant medication
  • Cleft patients
  • Lot of facial hair
  • Refused to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03682159


Locations
Layout table for location information
Belgium
University of Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Layout table for investigator information
Principal Investigator: Guy De Pauw, Prof. Dr. University of Ghent
Publications:
Layout table for additonal information
Responsible Party: Tandheelkunde, Prof. Dr. Guy De Pauw, University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT03682159    
Other Study ID Numbers: B670201629310
First Posted: September 24, 2018    Key Record Dates
Last Update Posted: February 4, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No